{"id":52677,"date":"2023-01-09T12:02:08","date_gmt":"2023-01-09T11:02:08","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-genetic-diagnostics-market-report-2023-rising-number-of-genetic-disorders-stimulates-growth-researchandmarkets-com\/"},"modified":"2023-01-09T12:02:08","modified_gmt":"2023-01-09T11:02:08","slug":"global-genetic-diagnostics-market-report-2023-rising-number-of-genetic-disorders-stimulates-growth-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-genetic-diagnostics-market-report-2023-rising-number-of-genetic-disorders-stimulates-growth-researchandmarkets-com\/","title":{"rendered":"Global Genetic Diagnostics Market Report 2023: Rising Number of Genetic Disorders Stimulates Growth – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Global Genetic Diagnostics Market – Analysis By Technology (Cytogenetic, Biochemical, Molecular), Type, Application, By Region, By Country: Market Size, Insights, Competition, Covid-19 Impact and Forecast (2023-2028)”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nThe Global Genetic Diagnostics market was valued at USD 10.68 billion in 2021 and is expected to grow at a CAGR of 10.31% during the forecast period of 2023-2028.\n<\/p>\n

\nThe genetic diagnostics market is driven by a rising number of genetic disorder cases. The growth of the Genetic Diagnostics market geographically is driven both by increasing awareness of the value of genetic testing among the population and increasing national investments in the healthcare sector by the Government and the organizations.\n<\/p>\n

\nGlobally, Cancer accounts for one-sixth of global deaths with up to 10-15% of all cancers caused by inherited genetic changes. Thus, genetic diagnostics play a crucial role in identifying the disease. Cardiovascular diagnostics account for the highest growth in coming years. Moreover, heart-related disorders are mostly inherited from parents to their children.\n<\/p>\n

\nCardiovascular genomic diagnostics testing, therefore, helps in detecting these inherited diseases such as cardiac channelopathies and congenital heart diseases.\n<\/p>\n

\nBy Type, the Prenatal and newborn genetic diagnostics segment dominates the market due to rising awareness among people about healthcare and increasing mortality rates caused by genetic disorders. Further, the rising geriatric population, technological advancements and increasing demand for genetic testing are factors dominating the share of Molecular Testing.\n<\/p>\n

\nThe increasing pattern of greater awareness among healthcare professionals, doctors and patients towards genetic diagnostics is further expected to strongly boost the global market as well as testing volume across several medical specialities. Further, the adoption of direct-to-consumer genetic testing kits in countries like the United States, China, and Japan is growing rapidly. With increasing technological adoptions, awareness programs, and a decline in costs, the market for DTC-GT kits is likely to witness a significant boost over the forecast period.\n<\/p>\n

\nScope of the Report:<\/strong>\n<\/p>\n